We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Laura Bloniarz has been assisting clients through the Perm Visa process since 2020.

As of 2023, Laura Bloniarz has succesfully submitted and recieved certification for 202 cases.

Laura Bloniarz is located in Richardoson, TEXAS, and has represented 12 employers for the Perm Visa Process

325
Cases Handled
202
Cases Certified
62.15%
Approval

Cases Handled by Laura Bloniarz

Case Number Case Status Job Title Industry Name Employer Name Year
A-20308-16015 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2021
A-22091-34452 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2023
A-21287-58593 Certified-Expired Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2023
A-20357-35823 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2021
A-19310-80128 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2020
A-21326-76469 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2022
A-21029-47353 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2021
A-20230-89097 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2021
A-22027-03521 Certified-Expired Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2023
A-21070-61132 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2021